Lupin Q4 Results
- BSE: 500257
- NSE: LUPIN
- ISIN: INE326A01037
- Sector: Biotechnology & Drugs
BSE
2,270.10
-3.40 (-0.15%)
-3.40 (-0.15%)Volume12.98 K
Updated: Tue 16 Jun, 2026 | 15:29:48
NSE
2,277.80
4.70 (0.21%)
4.70 (0.21%)Volume3.89 L
Updated: Tue 16 Jun, 2026 | 15:41:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹7,474.66 Cr.(31.89%)
- Operating Profit₹1,592.94 Cr.(77.20%)
- Profit After Tax₹1,460.34 Cr.(89.04%)
- Operating Margin21.31%(34.35%)
Note: Comparison is on YoY basis
Quarterly - Lupin Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,881.72 | 5,697.56 | 3.23% | 4,416.50 | 23.35% |
| Depreciation/ Amortization | 446.79 | 312.96 | 42.76% | 457.10 | 13.63% |
| Operating Income | 1,592.94 | 1,469.96 | 8.37% | 544.29 | 77.20% |
| Net Income | 1,460.34 | 1,175.55 | 24.23% | 359.43 | 89.04% |
| Other Operating Expenses Total | 2,209.27 | 1,936.62 | 14.08% | 1,489.97 | 30.92% |
| Net Income Before Taxes | 1,928.00 | 1,522.04 | 26.67% | 497.71 | 115.22% |
| Total Revenue | 7,474.66 | 7,167.52 | 4.29% | 4,960.79 | 31.89% |
| Selling/ General/ Admin Expenses Total | 1,242.69 | 1,143.28 | 8.70% | 900.22 | 24.11% |
| Diluted Normalized EPS | 34.07 | 42.13 | -19.13% | 7.85 | 102.35% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.